Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Mengwei Wu

Matched on OpenAlex author ID A5102385779. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. Integrated spatial omics of metabolic reprogramming and the tumor microenvironment in pancreatic cancer. Co-author DOI 10.1016/j.isci.2025.112681↗
  2. Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Co-author DOI 10.1038/s41419-024-06930-0↗
  3. Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2023.1216376↗
  4. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis. Co-author DOI 10.1016/j.lfs.2020.117857↗
  5. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.47629↗
  6. ITGA6 and RPSA synergistically promote pancreatic cancer invasion and metastasis via PI3K and MAPK signaling pathways. Co-author DOI 10.1016/j.yexcr.2019.03.022↗
  7. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2019.00996↗
  8. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer. Co-author DOI 10.1111/cas.13737↗
  9. Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium. Co-author DOI 10.1038/srep37606↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ziwen Liu · 5 shared papers, 2019–2025 · strength 1.03
  2. Qiyao Zhang · 2 shared papers, 2024–2025 · strength 0.50
  3. Peng Liu · 4 shared papers, 2016–2020 · strength 0.35
  4. Haoyi Jin · 4 shared papers, 2016–2020 · strength 0.35
  5. Xiaodong Tan · 4 shared papers, 2016–2020 · strength 0.35
  6. Yunhao Wu · 4 shared papers, 2016–2020 · strength 0.35
  7. Hao Wu · 1 shared paper, 2023 · strength 0.26
  8. Xiaobin Li · 2 shared papers, 2019–2020 · strength 0.26
  9. Hao Wu · 1 shared paper, 2024 · strength 0.26
  10. Hao Wu · 1 shared paper, 2025 · strength 0.25
  11. Yifan Yang · 2 shared papers, 2019–2020 · strength 0.20
  12. Xinlu Liu · 2 shared papers, 2019–2020 · strength 0.20
  13. Rui Liu · 1 shared paper, 2020 · strength 0.13
  14. Taiping Zhang · 1 shared paper, 2019 · strength 0.12
  15. Yupei Zhao · 1 shared paper, 2019 · strength 0.12
  16. Yukui Zhang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.